Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Tumor marker: pancreatic adenocarcinoma
CA-19-9
skeletal muscle malignant tumor
Leukocyte extravasation: tight binding
immunodeficiency states

2. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)
BRCA1 gene
p53 gene
alpha - fetoprotein
lung cancer incidence/mortality

3. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
p16 gene
Alkylating agents target
smooth muscle malignant tumor
lung cancer incidence/mortality

4. Lung tumor transcription factor (oncogene)
alpha - fetoprotein
L- myc gene
acanthosis nigricans (hyperpig and epidermal thickening)
Red (hemorrhagic) infarcts

5. Esophagus - stomach
primary amyloidosis
Barrett's esophagus (chronic GI reflux)
nitrosamines (smoked foods) target
smooth muscle malignant tumor

6. Rhabdomyosarcoma
smooth muscle malignant tumor
intrinsic apoptosis
skeletal muscle malignant tumor
Primary tumors that met to liver

7. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
DPC gene
erb - B2 gene
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
beta - hCG

8. Tumor marker: thyroid medullary carcinoma
radiation exposure
Resolution of inflammation
Primary tumors that met to bone
calcitonin

9. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
erb - B2 gene
paraneoplastic effects of leukemias and lymphomas
beta - hCG
paraneoplastic effects of renal cell carcinoma - hemangioblastoma

10. Hemangioma
blood vessels benign tumor
blood cell malignant tumors
Chronic inflammatory mediators
Free radical eliminators

11. Adenoma - papilloma
Neoplasm associated with Down Syndrome
benign epithelial tumor
Rb gene
lung cancer incidence/mortality

12. Neuroblastoma transcription factor (oncogene)
N- myc gene
blood vessels malignant tumor
p16 gene
bcl -2 gene

13. Colonic adenocarcinoma
ulcerative colitis
Rb gene
bone benign tumor
nitrosamines (smoked foods) target

14. 32%/18% female
Leading cause of death in the US
fat benign tumor
breast cancer incidence/mortality
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)

15. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)
Primary tumors that met to liver
WT1 gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
Rb gene

16. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Necrosis
Primary tumors that met to bone
Primary tumors that met to brain
Primary tumors that met to liver

17. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
L- myc gene
PSA
Chronic inflammatory mediators
calcitonin

18. Solid tissues with single blood supply. Heart - kidney and spleen.
Pale infarcts
Prostatic acid phosphatase
paraneoplastic effects of leukemias and lymphomas
CCl4 target

19. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
cigarette smoke target
DCC gene
Paget's bone disease
Primary tumors that met to liver

20. Adenocarcinoma - papillary carcinoma
smooth muscle benign tumor
radiation exposure
malignant epithelial tumor
malignant >1 cell type tumor

21. Skin (SqCC) - liver (angiosarcoma)
CA-19-9
arsenic target
cirrosis (alcohol - hepB or C)
smooth muscle benign tumor

22. Hyperuricemia (excess NA turnover)
c - myc gene
CA-125
BRAC2 gene
paraneoplastic effects of leukemias and lymphomas

23. Tumor marker: prostate carcinoma marker.
TRAP
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
Prostatic acid phosphatase
smooth muscle malignant tumor

24. 32%/13% male
prostate cancer incidence/mortality
bcl -2 gene
extrinsic apoptosis
fat benign tumor

25. Osteoma
Leukocyte extravasation: tight binding
blood cell malignant tumors
bone benign tumor
cigarette smoke target

26. Hyperplasia - metaplasia - dysplasia
S-100
fat malignant tumor
vinyl chloride target
Reversible - plasias

27. Breast cancer 13q tumor suppressor (DNA repair protein)
BRAC2 gene
alpha - fetoprotein
Autoimmune (Hashimoto's - myasthenia gravis)
paraneoplastic effects of thymoma - small cell lung carcinoma

28. Melanoma 9p tumor suppressor
Neoplasm associated with xeroderma pigmentosum (albinism)
c - myc gene
N- myc gene
p16 gene

29. AL
primary amyloidosis
Pale infarcts
lung cancer incidence/mortality
Free radical eliminators

30. Bacterial products (CLIK):C5a - LTB4 - IL-8 - Kallikrein
dysplastic nevus
blood vessels malignant tumor
intrinsic apoptosis
Leukocyte extravasation: migration

31. Lipoma
lung cancer incidence/mortality
bone benign tumor
fat benign tumor
blood vessels benign tumor

32. Secondary osteosarcoma and fibrosarcoma

33. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
dysplastic nevus
Primary tumors that met to brain
benign >1 cell type tumor
Leading cause of death in the US

34. Aggressive malignant lymphomas (non - Hodgkin's) and Kaposi's sarcoma
Leukocyte extravasation: rolling
AIDS
Resolution of inflammation
calcitonin

35. Lung - liver - intestine or following reperfusion.
Red (hemorrhagic) infarcts
benign >1 cell type tumor
Leukocyte extravasation: tight binding
ras gene

36. Cancer
L- myc gene
cigarette smoke target
Second - leading cause of death in the US
ret gene

37. Lymphoma

38. ACTH or ACTH- like peptide
bcl -2 gene
paraneoplastic effects of small cell lung carcinoma
intrinsic apoptosis
skeletal muscle benign tumor

39. Colon carcinoma GTPase (oncogene)
breast cancer incidence/mortality
Second - leading cause of death in the US
prostate cancer incidence/mortality
ras gene

40. Angiosarcoma
Colon and rectal cancer incidence
DCC gene
Bombesin
blood vessels malignant tumor

41. Membrane lipid peroxidation - protein modification and DNA breakage.
Leukocyte extravasation: diapedesis
Free radical cell damage
aflatoxin target
Necrosis

42. PECAM-1
Leukocyte extravasation: diapedesis
Primary tumors that met to brain
fat benign tumor
S-100

43. Liver (hepatocellular carcinoma)
BRAC2 gene
dysplastic nevus
intrinsic apoptosis
aflatoxin target

44. Leukemia - lymphoma
CEA
blood cell malignant tumors
Rb gene
DCC gene

45. Lung (mesothelioma and bronchogenic carcinoma)
Primary tumors that met to brain
asbestos target
malignant mesenchyme tumor (general)
intrinsic apoptosis

46. All - AML
Alkylating agents target
benign >1 cell type tumor
Neoplasm associated with Down Syndrome
bcl -2 gene

47. Vascular: E and P- selectin Leukocyte: Sialyl Lewis
asbestos target
benign epithelial tumor
Leukocyte extravasation: rolling
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants

48. Mature teratoma in women
Primary tumors that met to liver
blood vessels benign tumor
benign >1 cell type tumor
Autoimmune (Hashimoto's - myasthenia gravis)

49. Leiomyosarcoma
Neoplasm associated with xeroderma pigmentosum (albinism)
lung cancer incidence/mortality
Free radical eliminators
smooth muscle malignant tumor

50. MEN type II and III tyrosine kinase (oncogene)
ret gene
causes of increased ESR
Primary tumors that met to bone
Neoplasm associated with Down Syndrome